Krystal Biotech (KRYS) SEC Filings & 10K Form

$155.68
-3.37 (-2.12%)
(As of 04/25/2024 ET)

Recent Krystal Biotech SEC Filings

DateFilerForm TypeView
04/04/2024
3:08 PM
Krystal Biotech (Filer)
Form DEF 14A
04/04/2024
3:09 PM
Krystal Biotech (Filer)
Form DEFA14A
03/11/2024
7:24 PM
Krishnan Krish S (Reporting)
Krystal Biotech (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2024
7:27 PM
Krishnan Suma (Reporting)
Krystal Biotech (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2024
3:36 PM
Krishnan Krish S (Reporting)
Krystal Biotech (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/11/2024
3:37 PM
Krishnan Suma (Reporting)
Krystal Biotech (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/01/2024
7:20 PM
Krystal Biotech (Issuer)
ROMANO KATHRYN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/01/2024
7:09 PM
Krishnan Krish S (Reporting)
Krystal Biotech (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/01/2024
7:13 PM
Krishnan Suma (Reporting)
Krystal Biotech (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/01/2024
7:16 PM
Krystal Biotech (Issuer)
ROMANO KATHRYN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2024
8:39 PM
Krishnan Suma (Reporting)
Krystal Biotech (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2024
8:33 PM
Krystal Biotech (Issuer)
ROMANO KATHRYN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2024
8:36 PM
Krishnan Krish S (Reporting)
Krystal Biotech (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/26/2024
12:35 PM
Krystal Biotech (Subject)
ROMANO KATHRYN (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/26/2024
6:59 AM
Krystal Biotech (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/26/2024
7:04 AM
Krystal Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/26/2024
6:49 AM
Krystal Biotech (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/14/2024
8:25 AM
Avoro Capital Advisors LLC (Filed by)
Krystal Biotech (Subject)
Form SC 13G/A
01/29/2024
2:26 PM
Krystal Biotech (Subject)
Form SC 13G/A
01/24/2024
4:44 PM
Krystal Biotech (Issuer)
Romano Kathryn (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/22/2024
10:43 AM
Krystal Biotech (Subject)
Romano Kathryn (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/12/2023
4:17 PM
Krishnan Krish S (Reporting)
Krystal Biotech (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/12/2023
4:23 PM
Krishnan Suma (Reporting)
Krystal Biotech (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2023
3:19 PM
Krishnan Krish S (Reporting)
Krystal Biotech (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/11/2023
3:20 PM
Krishnan Suma (Reporting)
Krystal Biotech (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/06/2023
6:08 AM
Krystal Biotech (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/06/2023
6:10 AM
Krystal Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/02/2023
11:07 AM
Krystal Biotech (Subject)
ORTH ANDREW C. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/12/2023
4:59 PM
Krishnan Krish S (Reporting)
Krystal Biotech (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/12/2023
5:01 PM
Krishnan Suma (Reporting)
Krystal Biotech (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/11/2023
3:16 PM
Krishnan Suma (Reporting)
Krystal Biotech (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/11/2023
3:16 PM
Krishnan Krish S (Reporting)
Krystal Biotech (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/21/2023
4:30 PM
Krystal Biotech (Subject)
ORTH ANDREW C. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/16/2023
3:57 PM
Krystal Biotech (Subject)
ORTH ANDREW C. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/15/2023
3:56 PM
Krystal Biotech (Subject)
ORTH ANDREW C. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/10/2023
5:06 PM
Krystal Biotech (Subject)
ORTH ANDREW C. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/07/2023
7:18 AM
Krystal Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/07/2023
6:07 AM
Krystal Biotech (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/07/2023
6:13 AM
Krystal Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/18/2023
3:05 PM
Krystal Biotech (Filer)
Form S-3ASR
07/03/2023
3:35 PM
Krystal Biotech (Issuer)
Mazzacco Catherine (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
“Retirement Secret” Showed 995% Gain Last Time We Shared It (Ad)

Central Banks Buying Gold in Record Numbers Most folks have completely missed the fact that the world's Central Banks have been quietly gobbling up as much gold as they can… Stacking it in their locked vaults on pallets in record numbers.

Find out why right here (and see what you can do to get in too with just a few dollars).
07/03/2023
3:20 PM
JANNEY DANIEL (Reporting)
Krystal Biotech (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2023
3:24 PM
Krystal Biotech (Issuer)
Mason Christopher (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2023
3:27 PM
Krystal Biotech (Issuer)
ROSSI DINO A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2023
3:31 PM
Krystal Biotech (Issuer)
Sutherland Everett Rand (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2023
3:16 PM
Gangolli Julian S (Reporting)
Krystal Biotech (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/09/2023
6:00 PM
Krystal Biotech (Issuer)
ORTH ANDREW C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/09/2023
6:03 PM
JANNEY DANIEL (Reporting)
Krystal Biotech (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/02/2023
5:21 PM
Krishnan Krish S (Reporting)
Krystal Biotech (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/02/2023
5:23 PM
Krishnan Suma (Reporting)
Krystal Biotech (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2023
3:23 PM
Krishnan Suma (Reporting)
Krystal Biotech (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/22/2023
3:35 PM
Krystal Biotech (Subject)
Romano Kathryn (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/22/2023
6:32 AM
Krystal Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/11/2023
6:33 AM
Krystal Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/10/2023
8:45 AM
FMR LLC (Filed by)
Krystal Biotech (Subject)
Form SC 13G/A
05/08/2023
7:48 AM
Krystal Biotech (Filer)
Form 424B5
05/08/2023
7:51 AM
Krystal Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/08/2023
7:25 AM
Krystal Biotech (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/08/2023
7:27 AM
Krystal Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:KRYS) was last updated on 4/26/2024 by MarketBeat.com Staff

From Our Partners